Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VitaminShoppe.com

This article was originally published in The Tan Sheet

Executive Summary

Second quarter sales increased to $8.6 mil. from $2.4 mil. in the year-ago period, although consecutive-period revenues dropped from $9.3 mil., the company says July 13. The Nasdaq-listed firm gained 35,000 new shoppers in the quarter, bringing its total customer base to 189,000. Repeat customers made up half of all business for the quarter, VitaminShoppe notes, and the average shopping basket totaled about $75. Similar to other health product e-tailers, Wall Street has not looked kindly on the stock, which fell 67.2% to 1-5/16 in the second quarter (1see story, p. 10)

You may also be interested in...



Numico/Rexall Deal Precursor To Supplement Industry M&A Wave

Royal Numico's acquisition of Rexall Sundown spurred an almost 70% jump in the supplement maker's second-quarter stock price and may spawn a wave of mergers and acquisitions throughout the nutritionals category.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel